In a fecal immunochemical diagnostic test, antibodies are used to detect blood in the stool, which bind to a blood protein called hemoglobin found in red blood cells (RBC). A positive result of a fecal immunochemical diagnostic test may be a sign of colorectal cancer, polyps, ulcers or hemorrhoids. Blood vessels are usually very fragile and therefore easily damaged. The passage of stool can cause bleeding. If the fecal immunochemical diagnostic test results are positive, further colonoscopy is required for further research.
This report contains market size and forecasts of Fecal Immunochemical Diagnostic Tests in Global, including the following market information:
Global Fecal Immunochemical Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fecal Immunochemical Diagnostic Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fecal Immunochemical Diagnostic Test Cassette Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fecal Immunochemical Diagnostic Tests include Thermo Fisher Scientific Inc., Sysmex Sverige, BTNX Inc., Menarini Diagnostics s.r.l, Polymedco Inc., Fujirebio Inc., bioMerieux and Kyowa Medex Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fecal Immunochemical Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fecal Immunochemical Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fecal Immunochemical Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
Fecal Immunochemical Diagnostic Test Cassette
Fecal Immunochemical Diagnostic Tests Analyzer
Fecal Immunochemical Diagnostic Test Mailer
Global Fecal Immunochemical Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fecal Immunochemical Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
Cancer Centers
Nursing Homes
Hospitals
Homecare Settings
Global Fecal Immunochemical Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fecal Immunochemical Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fecal Immunochemical Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fecal Immunochemical Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific Inc.
Sysmex Sverige
BTNX Inc.
Menarini Diagnostics s.r.l
Polymedco Inc.
Fujirebio Inc.
bioMerieux
Kyowa Medex Co., Ltd.